CapsoVision

CapsoVision

CV
United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

CV · Stock Price

USD 7.19+3.69 (+105.43%)
Market Cap: $360.9M

Historical price data

Market Cap: $360.9MFounded: 2006HQ: United States

Overview

CapsoVision's mission is to advance gastrointestinal diagnostics through its proprietary, panoramic capsule endoscopy technology. The company has achieved significant milestones, including FDA clearance for patients as young as two years old and for remote ingestion, expanding access and convenience. Its strategy centers on leveraging its unique 360° imaging and cloud-based software platform to capture market share in the small bowel capsule endoscopy segment by offering superior diagnostic capabilities and a streamlined, cost-effective model for providers.

Gastroenterology

Technology Platform

A wire-free capsule endoscopy platform featuring a 360° panoramic viewing capsule with onboard data storage and a cloud-based software suite for remote video review and analysis.

Funding History

4
Total raised:$70M
IPO$20M
Series C$30M
Series B$15M
Series A$5M

Opportunities

Expansion into the pediatric market (FDA-cleared for ages 2+) and remote ingestion protocols present significant new addressable patient populations.
The zero-capex, cloud-based model is highly attractive for outpatient clinics and ASCs, enabling rapid, capital-efficient scaling.

Risk Factors

Facing intense competition from the deep-pocketed market leader (Medtronic's PillCam).
Commercial success is heavily dependent on convincing gastroenterologists to switch from established systems, requiring flawless execution of sales and marketing strategies.

Competitive Landscape

Competes primarily against Medtronic's PillCam (axial view) and other international capsule systems. Key differentiators are its 360° panoramic imaging, which may improve diagnostic yield, and its completely wire-free, cloud-based patient experience and provider workflow.

Company Timeline

2006Founded

Founded in United States

2010Series B

Series B: $15.0M

2013Series C

Series C: $30.0M

2014IPO

IPO — $20.0M